We're the biggest little bank in the biggest little state. What does that mean for our customers? It means our bank operates with a can-do attitude--the very same mindset that drives the individuals, families and businesses that bank with us. Then we add in legendary customer service. Freedom is known in every corner of the Ocean State (and beyond) as always willing to go the extra nautical mile for our customers.And to complement our group of experienced customer service representatives, mortgage experts and commercial banking specialists, we offer the very latest financial products and…
TruAcuity is involved in 2 service lines *Recovery Audit & *Strategic Sourcing primarily to HealthCare and Government Business Sectors. TruAcuity was started with the mission to provide these previously underserved "Sectors" utilizing post- transactional analysis and recovery to look forward ;we predict profit recovery . The service is provide by a veteran team of P2P and Supply Chain sourcing professionals drawn from some of the largest accounting and management consulting firms in the world. The professional service group is supported by a highly efficient IT department who perfected the…
Paxerol™ Introduction - An Unmet Medical NeedNocturia, the frequent need to urinate at night, afflicts 2.2B people. Our patented drug to prevent nocturia is a fixed dose extended release combination of safe drugs that reduces nocturia by 33-100%. We are seeking $2.6M to launch the drug in Europe Q1 2015 and complete one clinical trial before licensing our patents to a big pharma company in mid-2015. Since we are using low doses of known safe drugs for a new purpose, the FDA approval path is very fast.Nocturia, a sometimes deadly condition, causes insomnia, fatigue, depression, and lower…
TotipotentRX Corporation is engaged in the research, development, and commercialization of cell-based therapeutics for use in regenerative medicine. We operate three distinct businesses to serve patients, physicians and partners: Therapeutics Division Contract Services Division Cell Manufacturing and Banking Division The company has developed 10 autologous 60-90 minute bedside treatments in the areas of cardiology, vascular, and orthopedic medicine. TotipotentRX announced the significant top line results of its Phase Ib (safety and efficacy) trial for no-option critical limb ischemia in…
GDB provides better security and flexibility than anything else commercially available (maybe even including government security), and yet it is economical and simple to deploy. So you can get out of the IT business and focus instead on your own business. All data is encrypted – at rest on your device, in transit, and at rest on your network or within the cloud. Our biometric scanner reads 400 data points to validate each fingerprint. We can use additional identity tokens if desired. Smart cards, pin codes, retinal scanners, voice recognition. You get the idea. We can even be configured to…
Vaxess Technologies is a venture-backed life sciences company developing novel heat-stable vaccine formulations based on its proprietary silk stabilization platform. We are committed to improving access to vaccines by enabling truly global products that can be more effectively delivered throughout both the developed and developing world.
With over 20 years of service to the high-risk industries, ATR is committed to improving process safety focused on human performance and technology solutions.ATR is the industry leader in mission-critical procedure software and competency assurance solutions, including e-learning management. ExxonMobil recently chose SmartProcedures as their long-term procedure management solution for Global Operations. Additionally, Flint Hills Resources, the refining and chemical division of Koch, also selected SmartProcedures as their corporate standard for 10 sites. ATR's largest customer is the New…
Innoveas International is a leading innovation company, transforming world class technologies and innovative scientific ideas from universities and public research Institutions in Germany into game-changing enterprises. The company invests in high impact innovations in the global healthcare, energy, digital and environmental sectors.
Lipella Pharmaceuticals Inc. is a privately held development-stage biotechnology company dedicated to improve patient care by developing novel products which focus on trans-mucosal therapy, delivering local treatments directly to their site of action. Lipella focuses on four therapeutic areas: urology, otorhinolaryngology, gastroenterology, and dermatology. In each of these areas, Lipella has liposomal therapies in various stages of development ranging from pre-clinical to early clinical in the U.S. and overseas.
OverviewFibeRio Technology Corp. ("FibeRio" or the "Company") has developed revolutionary Forcespinning™ technology to produce nanofibers at commercial scale. This Forcespinning approach has the potential to replace 50+ year old electrospinning technology which is an order of magnitude less productive, over 4x more expensive, limiting in terms of materials and volume capabilities, and results in hazardous waste and disposal issues. The market and applications for nanofibers is expected to grow dramatically over the next 10 years across almost every industry (filtration, energy, textiles,…
U-M Tech Transfer is the University organization responsible for the transfer of University technology to the marketplace.Mission:To effectively transfer University technologies to the market so as to generate benefits for the University, the community and the general public.
Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with severe and life-threatening rare diseases. Patients with these devastating diseases often have no effective treatment options, and they and their families suffer with little hope. Our goal is to deliver medical breakthroughs where none currently exist. We are driven because we know people's lives depend on our work.Our first commercial product is Soliris® (eculizumab), the world's first and only approved terminal complement inhibitor. Today, Soliris is approved in…
Applied Minerals is the leading producer of halloysite clay and advanced natural iron oxide solutions from its wholly-owned Dragon Mine property in Utah. Halloysite is aluminosilicate clay that forms naturally occurring nanotubes. In addition to serving the traditional halloysite markets for use in technical ceramics and catalytic applications, the Company has developed niche applications that benefit from the tubular morphology of its halloysite. These applications include carriers of active ingredients in paints,coatings and building materials, environmental remediation,agricultural…
SGS is the world’s leading inspection, verification, testing and certification company. SGS is recognized as the global benchmark for quality and integrity. With more than 80,000 employees, SGS operates a network of over 1,650 offices and laboratories around the world. We are constantly looking beyond customers’ and society’s expectations in order to deliver market leading services wherever they are needed. As the leader in providing specialized business solutions that improve quality, safety and productivity and reduce risk, we help customers navigate an increasingly regulated world.…
Hartley Medical is a world-class compounding pharmacy dedicated to providing the highest quality sterile pharmaceuticals for the treatment of pain and movement disorders.
Paratek Pharmaceuticals is focused on the discovery, development, and commercialization of medicines designed to save lives and alleviate suffering. Our lead product candidate, omadacycline, is the first in a new class of tetracyclines known as aminomethycyclines, with broad spectrum activity against Gram-positive, Gram-negative and atypical bacteria. Omadacycline is being developed as a once daily, oral and intravenous, empiric monotherapy for community acquired bacterial infections, particularly when antibiotic resistance is of concern. We initiated a Phase 3 registration study in acute…
MicronView, LLC (MV) combines innovative, optical technology and expertise to produce and distribute BAMS (BioAerosol Monitoring System), a leading patent-pending, real-time microbial monitor. BAMS provides test results instantaneously. It reduces both lost time and lost production costs, increases test results accuracy and mitigates consumer safety risk. The executive leadership team has worked together for more than 12 years and is the most uniquely experienced team with real-time microbial detection technology, worldwide.
Arcturus Therapeutics is an industry leader in the application of RNA technologies for the treatment of disease and improved quality of life. The company’s aim is to develop breakthrough technology and novel therapeutics for rare diseases for which there is no adequate treatment. Backed by a management team with extensive experience in the discovery and development of RNA medicines, Arcturus is on the forefront of research and development of RNA delivery technologies.
PharmaACE, founded in 2013, operates at the intersection of science, data, technology, and business strategy. Our consultants provide clients with innovative solutions based on deep industry insights, analytical expertise, and an unbiased perspective. With our focus on data analytics and modelling, we understand the unmet needs related to tools and technologies. Our IT journey, therefore, started hand in hand with our consulting practice. Today, our technology experts create customized platforms and tools and work on data analytics, using Big Data, Machine Learning, and AI.
Codagenix Inc. utilizes our breakthrough platform technology termed SAVE to construct live-attenuated viral vaccines against multiple targets. All live-attenuated vaccines that are currently used in the clinic were developed using a trial-and-error based method that pre-dates the discovery of the DNA double helix. Codagenix presents a breakthrough approach to live-attenuated vaccine design. No longer would a vaccine developer blindly passage their target virus to construct a vaccine. The SAVE platform relies on synthetic biology and the “re-designing” of a target virus’s entire genome…
